Salicylic Acid 28.5% Solution

Manufacturer
Cintex Services, LLC
Effective date
2025-10-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:02:07

Label at a glance#

ProductSalicylic Acid
Active ingredientSALICYLIC ACID
Label structure11 sections

Indications and uses

This product is indicated for the topical treatment and removal of common warts and plantar warts.

Dosage and administration

Prior to applying this product, soak wart in warm water for five minutes. Remove any loose tissue by gently rubbing with a washcloth, emery board, or pumice stone. Dry the wart site thoroughly. Using the brush applicator supplied, apply this product twice to the entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day or as directed by a physicia...

Label contents#

Full prescribing information#

Salicylic Acid 28.5% Solution (salicylic acid 28.5% extended release)

SPL UNCLASSIFIED SECTION


Rx Only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

DESCRIPTION:

DESCRIPTION SECTION

Each mL contains 285 mg of salicylic acid extended release in a film-forming virucidal solution consisting of acrylates copolymer, isopropyl alcohol, n-Butyl acetate, polyvinyl butyral, and trimethyl pentanyl diisobutyrate.

The pharmacologic activity of this product is generally attributed to the keratolytic activity of salicylic acid, which is incorporated into a polyacrylic, film-forming virucidal solution designed to cover the wart without the need for a bandage. The structural formula of salicylic acid is:

structurestructure

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Although the exact mode of action for salicylic acid in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

This product is indicated for the topical treatment and removal of common warts and plantar warts.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. Patients with diabetes or impaired blood circulation should not use this product. This product also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face.

WARNINGS: KEEP OUT OF REACH OF CHILDREN.

WARNINGS SECTION

This product is flammable. Keep away from fire or flame. Keep bottle tightly closed when not in use.

PRECAUTIONS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

PRECAUTIONS SECTION

If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. This product should not be allowed to contact normal skin surrounding the wart site, since localized irritation may occur. Treatment should be discontinued if excessive irritation occurs.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Localized irritation may occur if this product is applied to normal skin surrounding the wart; however irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed. To report a serious adverse event, call 1-855-899-4237.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Prior to applying this product, soak wart in warm water for five minutes. Remove any loose tissue by gently rubbing with a washcloth, emery board, or pumice stone. Dry the wart site thoroughly. Using the brush applicator supplied, apply this product twice to the entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day or as directed by a physician. Be careful not to apply to surrounding skin.

Clinically visible improvement normally occurs during the first or second week of therapy. Resolution may be expected after four to six weeks of this product’s use, though some warts may take longer to remove.

HOW SUPPLIED:

HOW SUPPLIED SECTION

1/3 fl. oz. (10 mL) bottles, NDC 24470-948-10

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing and excessive heat. Keep bottle tightly closed.

Manufactured for:
Cintex Services, LLC

Dallas, TX 75243

2500269 [00] Rev. 10/2025

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1487371salicylic acid 28.5 % Topical SolutionPSN1
1487371salicylic acid 285 MG/ML Topical SolutionSCD1
1487371salicylic acid 28.5 % Topical SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
24470-948-10Salicylic Acid1 in 1 CARTONSOLUTION11
24470-948-10Salicylic Acid10 mL in 1 BOTTLE, WITH APPLICATORSOLUTION101

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24470-948-10ML - Milliliter24470-94826b32ac1-a495-417f-b932-c4db0fa5ae4a12025-12-16

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 1 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24470-94824470-948-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Salicylic AcidSALICYLIC ACIDCintex Services, LLC4136d85b-8b73-08e7-e063-6394a90a353b2025-10-15Warnings, Adverse reactionsExact identifier
ndc (package): 24470-948-10
ndc (product): 24470-948
ndc11 (package): 24470094810
spl id: 4136d867-c2cd-01c2-e063-6394a90a428d
spl set id: 4136d85b-8b73-08e7-e063-6394a90a353b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.